NantHealth

NantHealth, a member of the NantWorks ecosystem of companies, is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare applies novel diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with large-scale, real-time biometric signal and phenotypic data to track patient outcomes and deliver precision medicine. For nearly a decade, NantHealth has developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets billions of molecular, clinical, operational and financial data points derived from novel and traditional sources, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.

Company Growth (employees)
Type
Public
HQ
Culver City, US
Founded
2007
Size (employees)
498 (est)+5%
NantHealth was founded in 2007 and is headquartered in Culver City, US

Key People/Management at NantHealth

Patrick Soon-Shiong

Patrick Soon-Shiong

Founder

NantHealth Office Locations

NantHealth has offices in Culver City and London
Culver City, US (HQ)
9920 Jefferson Blvd
London, GB
Warnford Court, 29 Throgmorten Street

NantHealth Financials and Metrics

NantHealth Financials

NantHealth's revenue was reported to be $22.5 m in Q1, 2017
USD

Revenue (Q1, 2017)

22.5 m

Gross profit (Q1, 2017)

3.5 m

Gross profit margin (Q1, 2017), %

15%

Net income (Q1, 2017)

(41.1 m)

EBIT (Q1, 2017)

(32.6 m)

Market capitalization (20-Oct-2017)

430.8 m

Cash (31-Mar-2017)

124.9 m
NantHealth's current market capitalization is $430.8 m.
USDQ1, 2017

Revenue

22.5 m

Cost of goods sold

19 m

Gross profit

3.5 m

Gross profit Margin, %

15%
USDFY, 2016

Accounts Payable

39.4 m
USDQ1, 2017

Cash

124.9 m

Accounts Receivable

8.9 m

Inventories

2.2 m

Current Assets

146.1 m
USDFY, 2016
USDQ1, 2017

Net Income

(41.1 m)

Accounts Receivable

8.9 m

Inventories

2.2 m

Accounts Payable

3.7 m
Y, 2017

Financial Leverage

1.7 x
Show all financial metrics

NantHealth Market Value History

Traffic Overview of NantHealth

NantHealth Online and Social Media Presence

NantHealth News and Updates

Cher sues NantHealth's Patrick Soon-Shiong alleging stock sale fraud

The legendary singer claims Soon-Shiong and other Altor board members hid the success of a promising cancer and AIDS/HIV drug.

Altor investors amend suit against Patrick Soon-Shiong, claim mogul paid off board members

Altor Bioscience stakeholders say the NantHealth CEO low-balled the company’s value and paid off two directors in an attempt to buy the company through a sweetheart deal.

Patrick Soon-Shiong sued over capital investment in biotech firm

A Precision Biologics stockholder is accusing the NantHealth founder and controlling board members of breaching contract and fiduciary duty.

Patrick Soon-Shiong acquires stake in 6 California hospitals

The move could help the NantHealth founder and billionaire biotech mogul, who is embroiled in various controversies, with precision medicine efforts.

NantHealth founder Soon-Shiong hit with lawsuit over attempted takeover

The lawsuit filed by D.C. attorneys Boyden Gray and Adam Walden alleges the biotech mogul is seeking to acquire Altor Bioscience through a sweetheart deal.

NantHealth's Soon-Shiong doubles down on 'fake news' claims

[Also: Politico uncovers more funding indiscretions from Patrick Soon-Shiong]Despite company losing $41 million in the first quarter, biotech mogul Patrick Soon-Shiong defended his company’s work and chastised what he called false reports.

NantHealth Company Life and Culture

You may also be interested in